Sarah Cannon Research Institute Showcases 85+ Oncology Research Presentations at ESMO 2026, Highlighting Advances Across Multiple Tumor Types

Contributed by: Business Wire

Logo

Tags

Research

FDA

Clinical Trials

Other Health

Biotechnology

General Health

Health

Science

Oncology

Other Science

Sarah Cannon Research Institute

More Like This

Sarah Cannon Research Institute Delivers Novel Oncology Research Insights through 155+ Accepted Abstracts & Presentations at the 2026 ASCO® Annual Meeting

Sarah Cannon Research Institute to Showcase Cancer Insights at 2025 ASCO® Annual Meeting

Sarah Cannon Research Institute to Present Latest Cancer Research Insights at 2024 ASCO® Annual Meeting

PR Newswire associated0

Veeva and Sarah Cannon Research Institute Form Strategic Collaboration to Advance Oncology Clinical Trials

Hengrui Pharma Previews ESMO Congress 2026 with 64 Research Findings Across Its Innovative Oncology Portfolio

Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology (ESMO) Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers

Incyte to Highlight Key Oncology Data Presentations at the European Society for Medical Oncology (ESMO) Congress 2026

Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types